Nutritional supplements that may be helpful: People with low
blood levels of antioxidants and those who eat few
antioxidant-rich fruits and vegetables have been reported to be at high risk for
cataracts.11 12
Vitamin B2 and
vitamin B3 are needed to protect glutathione, an
important antioxidant in the eye. Vitamin B2 deficiency has been linked to
cataracts.13 14 Older people taking 3 mg of vitamin B2 and 40 mg of
vitamin B3 per day were partly protected against cataracts in one trial.15 However,
the intake of vitamin B2 in China is relatively low, and it is not clear whether
supplementation would help prevent cataracts in populations where vitamin B2 intake is
higher.
The major antioxidants in the lens of the eye are vitamin
C16 and glutathione (a molecule composed of three amino acids).17 Vitamin C is needed to activate vitamin E,18 which in turn activates glutathione.
Both nutrients are important for healthy vision. People who take multivitamins or any supplements containing vitamins C or E
for more than 10 years have been reported to have a 60% lower risk of forming a
cataract.19
Vitamin C levels in the eye decrease with age.20 However, supplementing with
vitamin C prevents this decrease21 and has been linked to a lower risk of
developing cataracts.22 23 Healthy people are more likely to take
vitamin C and vitamin E supplements than those with cataracts according to some,24
but not all,25 studies. Dietary vitamin C intake has not been consistently
associated with protection from cataracts.26 27 Nonetheless, because
people who supplement with vitamin C have developed far fewer cataracts in some
research,28 29 doctors often recommend 500 to 1,000 mg of vitamin C
supplementation as part of a cataract prevention program. The difference between successful
and unsuccessful trials may be tied to the length of time people actually supplement with
vitamin C. In one preliminary study, people taking vitamin C for at least ten years showed a
dramatic reduction in cataract risk, but those taking vitamin C for less than ten years showed
no evidence of protection at all.30
Low blood levels of vitamin E have been linked to
increased risk of forming cataracts.31 32 Dietary vitamin E intake has
not been consistently associated with protection from cataracts.33 34
Vitamin E supplements have been reported to protect against cataracts in animals35
and people,36 though the evidence remains inconsistent.37 In one trial,
people who took vitamin E supplements had less than half the risk of developing cataracts,
compared with others in the five-year study.38 Doctors typically recommend 400 IU
of vitamin E per day as prevention. Smaller amounts (approximately 50 IU per day) have been
proven in double-blind research to provide no protection.39
Some,40 but not all,41 studies have reported that people eating more
foods rich in beta-carotene had a lower the risk of
developing cataracts. Supplementation with synthetic beta-carotene has not been found to
reduce the risk of cataract formation.42 It remains unclear whether natural
beta-carotene from food or supplements would protect the eye or whether beta-carotene in food
is merely a marker for other protective factors in
fruits and vegetables high in
beta-carotene.
People who eat a lot of spinach and kale, which are high in lutein
and zeaxanthin, carotenoids similar to beta-carotene, have been reported to be at low risk for
cataracts.43 44 Lutein, zeaxanthin, and beta-carotene offer the promise
of protection because they are antioxidants. It is quite possible, however, that lutein is
more important than beta-carotene, because lutein is found in the lens of the eye, while
beta-carotene is not.45 In one preliminary study, lutein and zeaxanthin were the
only carotenoids associated with protection from cataracts.46 People with the
highest intake of lutein and zeaxanthin were half as likely to develop cataracts as those with
the lowest intake.
The flavonoid,
quercetin may also help by blocking sorbitol accumulation in the eye.47 This
may be especially helpful for people with diabetes,
though no clinical trials have yet explored whether quercetin actually prevents diabetic
cataracts.
Are there any side effects or interactions? Refer to the individual supplement for
information about any side effects or interactions.
References:
1. Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham Eye Study: I.
Outline and major prevalence findings. Am J Epidemiol 1977;106:17–32.
2. Schocket SS, Esterson J, Bradford B, et al. Induction of cataracts in
mice by exposure to oxygen. Isr J Med Sci 1972;8:1596–601.
3. Palmquist B, Phillipson B, Barr P. Nuclear cataract and myopia during
hyperbaric oxygen therapy. Br J Ophthalmol 1984;68:113–7.
4. Schaumberg DA, Glynn RJ, Christen WG, et al. Relations of body fat
distribution and height with cataracts in men. Am J Clin Nutr
2000;72:1495–502.
5. Glynn RJ, Christen WG, Manson JE, et al. Body mass index. An
independent predictor of cataract. Arch Ophthalmol 1995;113:1131–7.
6. Hankinson SE, Seddon JM, Colditz GA, et al. A prospective study of
aspirin use and cataract extraction in women. Arch Ophthalmol
1993;111:503–8.
7. Hiller R, Podgor MJ, Sperduto RD, et al. A longitudinal study of body
mass index and lens opacities. The Framingham Studies. Ophthalmology
1998;105:1244–50.
8. Tavani A, Negri E, La Vecchia C. Selected diseases and risk of
cataract in women. A case-control study from northern Italy. Ann Epidemiol
1995;5:234–8.
9. Leske MC, Chylack LT Jr, Wu SY. The Lens Opacities Case-Control Study.
Risk factors for cataract. Arch Ophthalmol 1991;109:244–51.
10. Mohan M, Sperduto RD, Angra SK, et al. India-US case-control study of
age-related cataracts. India-US Case-Control Study Group. Arch Ophthalmol
1989;107:670–6. [published erratum appears in Arch Ophthalmol
1989;107:1288.]
11. Jacques PF, Chylack LT Jr. Epidemiologic evidence of a role for the
antioxidant vitamins and carotenoids in cataract prevention. Am J Clin Nutr
1991;53:352S–5S.
12. Knekt P, Heliovaara M, Rissanen A, et al. Serum antioxidant vitamins
and risk of cataract. BMJ 1992;305:1392–4.
13. Bhat KS. Nutritional status of thiamine, riboflavin and pyridoxine in
cataract patients. Nutr Rep Internat 1987;36:685–92.
14. Prchal JT, Conrad ME, Skalka HW. Association of presenile cataracts
with heterozygosity for galactosaemic states and with riboflavin deficiency. Lancet
1978; 1:12–3.
15. Sperduto RD, Hu TS, Milton RC, et al. The Linxian cataract studies.
Arch Ophthalmol 1993;111:1246–53.
16. Taylor A, Jacques PF, Nadler D, et al. Relationship in humans between
ascorbic acid consumption and levels of total and reduce ascorbic acid in lens, aqueous humor,
and plasma. Curr Eye Res 1991;10:751–9.
17. Reddy VN. Glutathione and its function in the lens—an overview.
Exp Eye Res 1990;150:771–8.
18. Packer JE, Slater TF, Wilson RL. Direct observation of a free radical
interaction between vitamin E and vitamin C. Nature 1979;278:737–8.
19. Mares-Perlman JA, Lyle BJ, Klein R, et al. Vitamin supplement use and
incident cataracts in a population-based study. Arch Ophthalmol
2000;118:1556–63.
20. Taylor A. Cataract: relationship between nutrition and oxidation.
J Am Coll Nutr 1993;12:138–46 [review].
21. Taylor A, Jacques PF, Nadler D, et al. Relationship in humans between
ascorbic acid consumption and levels of total and reduced ascorbic acid in lens, aqueous
humor, and plasma. Curr Eye Res 1991;10:751–9.
22. Jacques PF, Chylack LT Jr. Epidemiologic evidence of a role for the
antioxidant vitamins and carotenoids in cataract prevention. Am J Clin Nutr
1991;53:352S–5S.
23. Jacques PF, Chylack LT, McGandy RB, Hartz SC. Antioxidant status in
persons with and without senile cataract. Arch Ophthalmol 1988;106:337–40.
24. Robertson JMD, Donner AP, Trevithick JR. Vitamin E intake and risk of
cataracts in humans. Ann NY Acad Sci 1989;570:372–82.
25. Seddon JM, Christen WG, Manson JE, et al. The use of vitamin
supplements and the risk of cataract among US male physicians. Am J Public Health
1994;84:788–92.
26. Lyle BJ, Mares-Perlman JA, Klein BE, et al. Antioxidant intake and
risk of incident age-related nuclear cataracts in the Beaver Dam Eye Study. Am J
Epidemiol 1999;149:801–9.
27. Chasan-Taber L, Willett WC, Seddon JM, et al. A prospective study of
vitamin supplement intake and cataract extraction among U.S. women. Epidemiology
1999;10:679–84.
28. Robertson J McD, Donner AP, Trevithick JR. A possible role for
vitamins C and E in cataract prevention. Am J Clin Nutr 1991;53:346S–51S.
29. Hankinson SE, Stampfer MJ, Seddon JM, et al. Nutrient intake and
cataract extraction in women: a prospective study. BMJ 1992;305:335–9.
30. Jacques PF, Taylor A, Hankinson SE, et al. Long-term vitamin C
supplement use and prevalence of early age-related lens opacities. Am J Clin Nutr
1997;66:911–6.
31. Rouhiainen P, Rouhiainen H, Salonen JT. Association between low
plasma vitamin E concentration and progression of early cortical lens opacities. Am J
Epidemiol 1996;144:496–500.
32. Lyle BJ, Mares-Perlman JA, Klein BE, et al. Serum carotenoids and
tocopherols and incidence of age-related nuclear cataract. Am J Clin Nutr
1999;69:272–7.
33. Lyle BJ, Mares-Perlman JA, Klein BE, et al. Antioxidant intake and
risk of incident age-related nuclear cataracts in the Beaver Dam Eye Study. Am J
Epidemiol 1999;149:801–9.
34. Chasan-Taber L, Willett WC, Seddon JM, et al. A prospective study of
vitamin supplement intake and cataract extraction among U.S. women. Epidemiology
1999;10:679–84.
35. Trevithick JR, Creighton MO, Ross WM, et al. Modelling cortical
cataractogenesis: 2. In vitro effects on the lens of agents preventing glucose- and
sorbitol-induced cataracts. Can J Ophthalmol 1981;16:32–8.
36. Robertson J McD, Donner AP, Trevithick JR. A possible role for
vitamins C and E in cataract prevention. Am J Clin Nutr 1991;53:346S–51S.
37. Seddon JM, Christen WG, Manson JE, et al. The use of vitamin
supplements and the risk of cataract among US male physicians. Am J Public Health
1994;84:788–92.
38. Leske MC, Chylack LT Jr, He Q, et al. Antioxidant vitamins and
nuclear opacities. The Longitudinal Study of Cataract. Ophthalmology
1998;105:831–6.
39. Teikari JM, Virtamo J, Rautalahti M, et al. Long-term supplementation
with alpha-tocopherol and beta-carotene and age-related cataract. Acta Ophthalmol
Scand 1997;75:634–40.
40. Hankinson SE, Stampfer MJ, Seddon JM, et al. Nutrient intake and
cataract extraction in women: a prospective study. BMJ 1992;305:335–9.
41. Chasan-Taber L, Willett WC, Seddon JM, et al. A prospective study of
vitamin supplement intake and cataract extraction among U.S. women. Epidemiology
1999;10:679–84.
42. Teikari JM, Virtamo J, Rautalahti M, et al. Long-term supplementation
with alpha-tocopherol and beta-carotene and age-related cataract. Acta Ophthalmol
Scand 1997;75:634–40.
43. Hankinson SE, Stampfer MJ, Seddon JM, et al. Nutrient intake and
cataract extraction in women: a prospective study. BMJ 1992;305:335–9.
44. Chasan-Taber L, Willett WC, Seddon JM, et al. A prospective study of
carotenoid and vitamin A intakes and risk of cataract extraction in US women. Am J Clin
Nutr 1999;70:509–16.
45. Yeum K-J, Taylor A, Tang G, Russell RM. Measurement of carotenoids,
retinoids, and tocopherols in human lenses. Ophthalmol Vis Sci
1995;36:2756–61.
46. Lyle BJ, Mares-Perlman JA, Klein BE, et al. Antioxidant intake and
risk of incident age-related nuclear cataracts in the Beaver Dam Eye Study. Am J
Epidemiol 1999;149:801–9.
47. Varma SD, Mizuno A, Kinoshita JH. Diabetic cataracts and flavonoids.
Science 1977;195:205.
48. Van Acker SA, van den Berg DJ, Tromp MN, et al. Structural aspects of
antioxidant activity of flavonoids. Free Rad Biol Med1996; 20:331–42.
49. Salvayre R, Braquet P, et al. Comparison of the scavenger effect of
bilberry anthocyanosides with various flavonoids. Proceed Intl Bioflavonoids
Symposium, Munich, 1981, 437–42.
50. Bravetti G. Preventive medical treatment of senile cataract with
vitamin E and anthocyanosides: clinical evaluation. Ann Ottamol Clin Ocul
1989;115:109.